Abiopharma

🔍 Niew Jeffrey (Director)

Company: Knowles Corp (KN)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Sold 150,000 shares of Common Stock at $39.07 per share (Direct)
  Date: 2026-08-12 | Code: S | equity_swap_involved: 0 | shares_owned_after: 733,719.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 43,049 shares of Common Stock at $38.69 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 690,670.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 6,951 shares of Common Stock at $38.0 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 683,719.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 13, 2026.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.79 to $39.58, inclusive. The reporting person undertakes to provide to Knowles Corporation, any security holder of Knowles Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased/sold at each separate price within the ranges set forth in this footnote to this Form 4.
• F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $39.17, inclusive. The reporting person undertakes to provide to Knowles Corporation, any security holder of Knowles Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased/sold at each separate price within the ranges set forth in this footnote to this Form 4.